Document is current
Any future updates will be listed below
-
Authors
Diels, Sara
Cuypers, Bart
Tvarijonaviciute, Asta
Derudas, Bruno
Van Dijck, Evelien
Verrijken, An
Van Gaal, Luc F.
Laukens, Kris
Lefebvre, Philippe
Ceron, Jose J.
Francque, Sven
Vanden Berghe, Wim
Van Hul, Wim http://orcid.org/0000-0002-5065-7858
-
Funding
Funding for this research was provided by:
European Commission (LSHM-CT-2005-018734)
RESOLVE (FP7-305707)
GOA (FFB180348/36572)
Methusalem-OEC (FFB190208)
Fonds De La Recherche Scientifique - FNRS (12V5319N, 11E6921N, 1802154N)
- License Information
-
More Information
Article History
Received: 2 February 2021
Accepted: 29 July 2021
First Online: 13 August 2021
Declarations
:
: A written informed consent was obtained from each patient. The complete study protocol was performed according to the Declaration of Helsinki and approved by the Ethics Committee of the Antwerp University Hospital (EU consortium reference 6/25/125, Belgian registration number B30020071389). All authors had access to the study data and had reviewed and approved the final manuscript.
: Not applicable.
: LVG is a member of District 57 Speakers Bureau and has a professional relationship with NovoNordisk and AstraZeneca.
